TheProfitWatch

AMLX - Amylyx Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.42 1.3 (9.69%) 0.02 (0.14%) -0.04 (-0.27%) 0.07 (0.44%) --- 1.3 (9.69%) --- ---

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.46
Diluted EPS:
-0.46
Basic P/E:
-32.0
Diluted P/E:
-32.0
RSI(14) 1m:
32.81
VWAP:
14.73
RVol:

Events

Period Kind Movement Occurred At

Related News